Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01272999 · ClinicalTrials.gov registry record
Impact of Prevnar 13 on Ear Infections in Children
A clinical trial, sponsored by Pfizer.
- Completed
- Registry status
- 391
- Enrollment target
NCT01272999 is a clinical trial that has completed, run by Pfizer. The registered enrollment target is 391 participants.
The verdict
NCT01272999 has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- 391 participants
- Enrollment target
Study Summary
Prevnar (7 valent pneumococcal conjugate vaccine \[7vPnC\]) has been shown to be effective against ear infections in children. Prevnar 13 is a new vaccine that is similar to Prevnar. It is expected that the effectiveness of Prevnar 13 against ear infections in children will be similar to that observed following Prevnar. Pfizer has committed to conduct a postmarketing study of the impact of Prevnar 13 in reducing ear infections among children.
Interventions
- OTHER No intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 391 participants |
| Start Date | 2010-05-21 |
| Est. Completion | 2013-12-19 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01272999
The ClinicalTrials.gov registry entry for NCT01272999 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 391 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which No intervention is the first listed.
NCT01272999 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01272999 about?
NCT01272999 is a clinical study titled "Impact of Prevnar 13 on Ear Infections in Children". Prevnar (7 valent pneumococcal conjugate vaccine \[7vPnC\]) has been shown to be effective against ear infections in children. Prevnar 13 is a new vaccine that is similar to Prevnar. It is expected that the effectiveness of Prevnar 13 against ear infections in children will be similar to that observ...
What is the current status of trial NCT01272999?
This trial is currently completed. The enrollment target is 391 participants. The study started on 2010-05-21. Estimated completion is 2013-12-19.
What interventions are being tested in trial NCT01272999?
The interventions under investigation include: No intervention (OTHER).
Who is sponsoring clinical trial NCT01272999?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.